This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Efficacy of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years

This study is currently recruiting participants.
See Contacts and Locations
Verified June 2017 by Janssen Sciences Ireland UC
Sponsor:
Information provided by (Responsible Party):
Janssen Sciences Ireland UC
ClinicalTrials.gov Identifier:
NCT00799864
First received: November 26, 2008
Last updated: June 20, 2017
Last verified: June 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 27, 2024
  Estimated Primary Completion Date: January 10, 2020 (Final data collection date for primary outcome measure)